Just like any groundbreaking industry, the past of biotechnology has been marred with unrealistic expectations. Although each of the recent biotechnology startups seems to be an improvement from their past counterparts, these companies still appear to lean towards the tendency to overvalue their revenue projections and undervalue the breakeven time. They appear as if...
Read More ยป
